Endometriosis Market Growing Rapidly with Market Trends, Growth, Revenue and Future scope with Top Key Players

IndustryARC

Market Research Reports, Business Consulting Services & Analytics

Increase focus on woman health and easy availability of patient assistance program are some of the key factors driving the endometriosis market.

HYDERABAD, TELANGANA, INDIA, February 13, 2023 /EINPresswire.com/ -- The Endometriosis Market size is estimated to be $1.9Billion, growing at a CAGR of 2.9% during 2019-2024. Increase focus on woman health and easy availability of patient assistance program are some of the key factors driving the endometriosis market over the forecast period, 2019 to 2024. Women with endometriosis could also have endometrial cyst which is also known as ovarian cyst. This could lead to other complications like causing chronic pelvic pain and raise the overall risk for ovarian cancer. Laparoscopy is one of the most definitive ways to do endometriosis diagnosis. The disease is often misdiagnosed with fibroid tumors and adenomyosis.

Click here to browse the complete report summary:
https://www.industryarc.com/Report/17322/endometriosis-market.html

Key Takeaways

1. The growing prevalence of endometriosis has led to higher awareness among the patients regarding the endometriosis treatment. Further, there is rise in focus in research and development with the increase occurrence of the disease.

2. Government agencies are investing in healthcare infrastructure to provide better treatment facility to the patients. Thus more drugs and diagnosis equipment in line with the treatment of endometriosis are required thus driving the market further.

3. The market is controlled by high-cost hormone-based therapeutics, which plays a significant role in the treatment of endometriosis of the patient. Thus, companies such as Bayer and AbbVie are providing patient-assistance programs which helps to reduce the cost burden on the patients.

4. The accessibility of patient assistance programs for expensive drugs is expected to rise patient adherence to such drugs medications, which will in turn drive the market over the forecast period.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=17322

Segment Analysis

1. The endometriosis market by diagnosis type has been segmented into ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy and sonohysterography. The ultrasound segment held the largest market share in terms of revenue with 31.01%. Rising demand for minimal invasive and non-invasive diagnostic procedures coupled with innovation in technology is a key factor resulting in the revenue share.

2. The Endometriosis market by geography has been segmented into North America, South America, Europe, Asia Pacific and Rest of the World. North America held the largest endometriosis market share of 51.61% revenue wise, in 2018. The high prevalence of endometriosis in North America is driving market growth in the region. Europe followed North America in terms of revenue share in the same year. Further, Asia Pacific is expected to grow the fastest over the forecast period.

Competitive Landscape:

The top 5 players in the Endometriosis Industry are -

1. AbbVie Inc
2. Abbott
3. Ipsen
4. Bayer AG
5. Philogen

Click on the following link to buy the Endometriosis Market Report:
https://www.industryarc.com/reports/request-quote?id=17322

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.